Clinician's perspectives on the treatment of venous leg ulceration.

International Wound Journal
George H Cullen, Tania J Phillips

Abstract

Treatment of venous leg ulcers (VLU) represents a considerable challenge to the health care professional and to the patient alike. Much of the current literature regarding VLU focuses on either wound pathophysiology and treatment of chronic venous insufficiency or the patients' experience of the condition. We present two studies that examine more closely the clinicians' experience of treating VLU and reflect upon how that understanding may further enhance better outcomes for patients in the future. The first of these studies is a qualitative investigation of 49 clinicians treating VLU in the UK and USA. The second is a quantitative, online survey of 304 clinicians' beliefs, attitudes and practices in the UK, Germany and USA. Findings show that the clinicians' experience of treating VLU is often accompanied by frustration and dissatisfaction with treatment challenges and uncertain outcomes. Practices and treatment choices were found to vary widely and differ by countries. We conclude that a key aspect in improving VLU treatment is in listening to the frustrations of the clinician when considering new approaches to therapy.

References

Jul 1, 1994·Journal of the American Academy of Dermatology·T PhillipsR Lew
Jun 1, 1997·Journal of Vascular Nursing : Official Publication of the Society for Peripheral Vascular Nursing·S K ChaseA Savage
May 13, 1998·Journal of Advanced Nursing·J M Gibson, M Kenrick
Jun 6, 2000·International Journal of Nursing Practice·C HydeG Winder
Jul 25, 2000·Journal of Advanced Nursing·C E HallettK A Luker
Oct 7, 2000·Journal of Clinical Nursing·H KyngäsT Kroll
Aug 9, 2001·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·L L Husband
Apr 6, 2002·Journal of Wound Care·J Harker
Feb 13, 2003·Scandinavian Journal of Caring Sciences·Gunilla Strandberg, Lilian Jansson
Mar 11, 2004·Journal of Clinical Nursing·Anke PersoonTheo van Achterberg
Jul 30, 2005·Nursing Standard·Elaine Flaherty
Oct 22, 2005·Journal of Clinical Nursing·Britt Ebbeskog, Azita Emami
Dec 15, 2006·British Journal of Nursing : BJN·Janine Ashton, Patricia Price
Feb 6, 2007·Clinics in Dermatology·Chukwuemeka N Etufugh, Tania J Phillips
Jan 18, 2008·Journal of Vascular Surgery·Mark H MeissnerSeshadri Raju
Feb 12, 2008·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Hugo PartschSteven Zimmet
May 23, 2008·International Wound Journal·Christine Moffatt
Nov 20, 2008·Journal of Advanced Nursing·Ann Van HeckeTom Defloor

❮ Previous
Next ❯

Citations

May 2, 2014·International Wound Journal·Marlene A Varga, Samantha L Holloway
Dec 18, 2014·Revista da Escola de Enfermagem da U S P·Marcelo Henrique da SilvaDeíse Moura de Oliveira
Jul 28, 2017·International Journal of Qualitative Studies on Health and Well-being·Annica LagerinLena Törnkvist
Nov 16, 2012·The Cochrane Database of Systematic Reviews·Susan O'MearaJo C Dumville
Jun 28, 2018·Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine·Andreas ÄlgåCecilia Stålsby Lundborg
Jul 12, 2019·Journal of Wound Care·Janet L KuhnkeRobyn Jones Evans
Apr 1, 2021·Annals of Vascular Diseases·Rica TanakaHiroshi Mizuno

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.